0000920465-20-000086.txt : 20200603
0000920465-20-000086.hdr.sgml : 20200603
20200603160507
ACCESSION NUMBER: 0000920465-20-000086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200603
DATE AS OF CHANGE: 20200603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hearne Michael S
CENTRAL INDEX KEY: 0001759910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 20939997
MAIL ADDRESS:
STREET 1: 4147 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_159121468942434.xml
FORM 4
X0306
4
2020-06-01
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001759910
Hearne Michael S
C/O LA JOLLA PHARMACEUTICAL COMPANY
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
4.55
2020-06-01
4
A
0
100000
0
A
2030-06-01
Common Stock
100000.0
100000
D
The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
/s/ Michael Hearne
2020-06-01